2015, Number 5
<< Back
Rev Mex Neuroci 2015; 16 (5)
CADASIL: Description of a new mutation
Corrales-Arroyo MJ, Del Real-Francia MÁ, Valencia-Guadalajara C, López-García A, Giraldo-Restrepo N, López-Gallardo G
Language: Spanish
References: 17
Page: 48-53
PDF size: 132.58 Kb.
ABSTRACT
Introduction: The CADASIL is the acronym for
a systemic arteriopathy of autosomal dominant
inheritance, whose genetic alteration is located
in the NOTCH3 gene, on chromosome 19. It is
characterized by the appearance of symptoms of
repeat migraine attacks, usually with aura, stroke
recurrence, as well as cognitive impairment of
subcortical type.
Case report: We present the case of a patient
who suffered from migraine type headache from
several years. Later the syndrome was associated
with a profile consisting of hemiparesis and
hemihipoestesia. A new mutation for this disease,
located at codon 592, exon 11 of the Nocht-3 gene
was identified in the genetic study.
Conclusion: The present paper communicates
a case of CADASIL patients who is carrier of a new
mutation, not previously described in the literature.
REFERENCES
Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, et al. Cerebral autosomal dominant arteriopathy with subcortical ingars and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993; 3: 256-9.
Vaquez do Campo R, Morales-Vidal S, Randollph C, Chaddwick L, Biller J. Cadasil: descripción de una serie de 11 casos clínicos. Rev Neurol 2011; 52: 202-2010.
Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. ANN Neurol 1998; 44: 731-9.
Finsterer J. Neuromuscular implications in CADASIL. Cerebrovasc Dis 2007; 24: 401-4.
Ratzinger G, Ransmayr G, Romani n, Zelger B. CADASIL - an unuksual manifestation with prominent cutaneous involvement. VR J Dermatol 2005; 152:346-9.
Luna-Maldonado E, Aguirre-Acevedo DC, García-Ospina GP, Lopera F. Enfermedad periodontal como signo clínico precoz de la arteriopatía cerebral autosómica dominante con infartos subcorticales y leucoencefalopatía (CADASIL). Rev neurol 2009; 49: 520-3.
Skehan SJ, Hutchinson M, MacErlaine DP. Cerebral autosomal dominant arteriopaty with subcortical infarts and leukoencephalopathy: MR findings. AJNR Am J Neuroradiol 1995; 16: 2115-9.
Chabriat H, Levy C, Taillia H, Iba-ZiZen MT, Vahedi K, Joutel A, et al. Patterns of MRI lesions in CADASIL. Neurology 1998; 51: 452-7.
O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Phil D, et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001; 56: 628-12.
García-Estevez DA, Barros-Angueira F, Navarro C. CADASIL: comunicación de una familia con una nueva mutación p.G296C en el exón 6 del gen Notch-3. Rev Neurol 2003; 51: 729-732.
Joutel A, Corpechot C, Ducros A, Vahedi K, Chabrial H, Mouton P, et al. Notch3 mutatiions in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383: 707-10.
Joutel A, Dodick DD, Parisi JE, Cecillon M, Tournier-Lasserve E, Bousser MG. De novo mutation in the Notch3 gene causing CADASIL. Annals of Neurology 2000; 47: 388-391.
Del Río Espínola A, Solé E, Montaner J. Fisiopatología del CADASIL. Med Clin (Barc) 2010; 135: 222-30.
Shin HK, Louvi A, Kim HH, Savitz SI, et al. Linking Notch signaling to ischemic stroke. Proc Tal Acad Sci USA 208; 105: 4856-61.
Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 2004; 18: 161-4.
http://neurowikia.es/content/ictus-de-base-gen%C3%A9tica-cadasil
Monet-Laprete M, Bardot B, Lemaire B, Domenga V, Godin O, Dichangs M. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain 2009; 132: 1601-12.